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We have discovered a family of small secreted proteins in Homo sapiens and Mus musculus. The IGF-like (IGFL) genes encode proteins of
approximately 100 amino acids that contain 11 conserved cysteine residues at fixed positions, including two CC motifs. In H. sapiens, the family
is composed of four genes and two pseudogenes that are referred as IGFL1 to IGFL4 and IGFL1P1 and IGFL1P2, respectively. Human IGFL
genes are clustered together on chromosome 19 within a 35-kb interval. M. musculus has a single IGFL family member that is located on
chromosome 7. Further, evolutionary analysis shows a lack of direct orthology between any of the four human members and the mouse gene. This
relationship between the mouse and the human family members suggests that the multiple members in the human complement have arisen from
recent duplication events that appear limited to the primate lineage. Structural considerations and sequence comparisons would suggest that IGFL
proteins are distantly related to the IGF superfamily of growth factors. IGFL mRNAs display specific expression patterns; they are expressed in
fetal tissues, breast, and prostate, and in many cancers as well, and this pattern is consistent with that of the IGF family members.
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cloning; Protein family informatics; Gene duplicationThe completion of the human and mouse genomes now
allows the mapping of entire gene families and their
orthologous relationships. Such work has been done recently
for important protein families, such as the tumor necrosis factor
superfamily [1], the insulin growth factor (IGF) family [2], the
receptor tyrosine kinase family [3], and the carcinoembryonic
antigen family [4] and will be gradually extended to all protein
families within the human genome. We have recently finished
the characterization of two protein families, the C1q-domain-
containing protein family and the progestin and adipoQ receptor
family [5,6]. The objective of these studies was to define the
complete complement in the human genome, including
transcript variants and pseudogenes.
In a previous study [7], we identified the TAFA family as a
novel secreted family marked by conserved cysteine residues.
With the aim of identifying potential protein therapeutics, we⁎ Corresponding author. Fax: +1 650 517 8041.
E-mail address: wfunk@nuvelo.com (W.D. Funk).
0888-7543/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2006.05.012have continued a broad review of potential secreted protein
families to distill the complete complement of each family in the
human genome.
The IGF family includes a large proportion of potentially
valuable therapeutic proteins; a total of 10 active peptides have
been identified, including insulin, insulin-like growth factors I
and II (IGF-1, IGF-2), relaxin 1–3, Leydig cell-specific insulin-
like peptide (LeyIL), early placenta insulin-like peptide (EPIL),
and insulin-like peptides 5 and 6 [2,8]. Within the mature
protein, all members have six cysteines split into two chains (A
chain, B chain). The cysteine patterns are CGX10C in B chain
and CCX3CX8C in A chain. Structurally, the first A-chain
cysteine is linked to the third cysteine within the A chain by a
disulfide bond. The second and fourth cysteines in A chain are
linked by interchain disulfide bonds to the two cysteines in B
chain.
The IGF signaling system plays a critical role in cellular
energy metabolism and in growth and development, especially
prenatal growth [9,10]. Insulin is involved in the regulation of
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physiological functions [8]. In humans, IGF-1 and IGF-2
maintain distinct expression patterns [11]. IGF-1 is the primary
protein involved in the cellular response to growth hormone,
particularly in bone growth and cartilage metabolism [12,13].
Relaxins play a critical role in the development of the mammary
gland as well as in many of the physiological processes
involved in pregnancy and labor, including growth and
softening of the cervix. EPIL is expressed during the “invasive”
phase of placental development. In males, LeyIL has been
shown to be involved in testes descent. In addition, IGFs have
powerful antiapoptotic effects [9]. The IGF system has also
been implicated in various pathological conditions and is
thought to play a prominent role in tumorigenesis [10]. High
levels of circulating IGF-1 constitute a risk factor for the
development of breast, prostate, lung, and colon cancer.
Therefore, IGF proteins are important not only for growth,
but also for the development of male and female reproductive
systems and cancer development and progression.
We have discovered a novel secreted family of human
proteins that we have named the IGF-like (IGFL) family. The
family is composed of four expressed genes and two
pseudogenes marked by 11 conserved cysteine residues,
including two CC motifs, and IGFL members are predicted to
share structural homology to the IGF family.
Results
IGFL family genes encode small secreted proteins
We discovered the IGFL family by applying a strategy that
sorts available EST and cDNA sequences into contigs [7]. The
algorithm is based on TBLASTN similarities of the assembledFig. 1. ClustalW alignment of IGFL family members in human and mouse. Signal
Asterisks (*) indicate identical residues, colons (:) conserved residues, and periods (.)
representing the predicted mature protein, pair-wise identity is 26–63%. The aminosequences within themselves [14,15]. Namely, if there is a novel
protein family within the assembled contigs, family members
will share statistically significant protein-level sequence
similarities. Gene clusters are generated based on TBLASTN
S score greater than 150 and putative protein sequences are
extracted based on TBLASTN alignments. We then selected
specific clusters for further review based on the presence of at
least one putative protein containing a signal peptide [16] and
the absence of putative proteins containing a predicted
transmembrane domain. In this way, we are able to narrow
down to a manageable set of clusters that are likely to encode
novel secreted protein families.
The identified IGFL cluster initially contained three
members and these contigs were then extended to complete
coding sequences employing additional information from
genomic sequences. We have named these IGFL1, IGFL2,
and IGFL3. Upon mapping these sequences to the human
genome, we observed that the three members clustered together
on chromosome 19. A more detailed look at this genomic
interval revealed one additional potential IGFL gene and two
likely pseudogenes, based on interrupted coding regions. We
designed primers to each of the predicted family members and
were able to confirm the transcription of coding mRNAs for
IGFL1 to IGFL4, while the two putative pseudogenes failed to
produce PCR products from any of the cDNA sources tested,
suggesting that these are not transcribed genes (data not shown).
Mapping the human IGFL genes to the mouse genome
identified only a single homologous sequence that cannot be
assigned direct orthology with any single human IGFL
sequence. Fig. 1 shows the ClustalW alignment [17] of the
five predicted amino acid sequences of the IGFL family from
human and mouse. The divergent leading signal peptide
sequence is followed by a more conserved region representingpeptides are in italic and underlined. Conserved cysteine residues are in bold.
semiconserved residues. The overall pair-wise identity is 27–55%; in the region
acid lengths of the mature proteins are indicated.
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brane domains would suggest that these proteins are secreted
and the lengths of the predicted mature proteins range from 87
to 118 aa. Interestingly, 11 regularly spaced cysteine residues
can be found in the mature proteins. In human, the conserved
Cys residues follow the common pattern CX5CX10CCX13-
CX2–3CX4CX3CCX12–22CX8–10C, where C represents a con-
served cysteine residue and X denotes non-cysteine amino
acids, and this arrangement is conserved in the mouse protein as
well.
The most striking sequence conservation among the
proteins is the presence of two CC motifs within a 25-aa
interval. Another feature of this family is the conservation of
residues immediately following the conserved cysteines. For
example, there are two CG motifs that are repeated twice in
each of the human IGFLs. In addition, there are CT and
CFE motifs conserved among all members. The highest
sequence divergence occurs, as expected, within the signal
peptide region. Within the mature protein, the human IGFLs
share sequence identities that range between 26% (hIGFL1/
4) and 63% (IGFL2/3). Interestingly, the mouse IGFL
member shares low identity with all the human members
(ranges from 22% to 39%), although all of the 11 cysteines
are conserved.
Genomic organization of IGFL genes
IGFL cDNAs are composed of five exons, with four
encoding segments of the ORF. Since all IGFL genes have
similar intron/exon patterns, we present the organization of
IGFL1 as an example (Fig. 2A). The 5′ untranslated region
(UTR) is contained in the first exon and part of the second. TheFig. 2. Genomic organization of human IGFL genes. (A) Exon patterns and structur
which the first two code for the signal peptide and the last two code for the mature
residues in exon IV are conserved for all IGFL members with minor insertion/deleti
pseudogenes. Genomic mapping of the IGFL genes shows clustering in a short inter
indicates a confirmed gene, and green indicates a pseudogene.second and third exons encode the signal peptide, while the
mature protein is encoded by the fourth and fifth exons.
The four members of the IGFL family and two pseudogenes
are located within a 220-kb interval of chromosome 19 (within
51,220–51,440 kb of gi29824590 of the completed chromoso-
mal 19 sequence). Fig. 2B shows the genomic mapping of all
four members. IGFL1 and IGFL2 are encoded on the strand
opposite that of IGFL3 and IGFL4. Coding sequence frameshifts
are apparent for the two identified human IGFL pseudogenes on
chromosome 19, and in a more detailed review of these regions,
multiple additional differences were observed in comparison to
IGFL4. For example, in one of the IGFL pseudogenes
(IGFL1P1), the first CC motif is mutated to CY, and the 5th
cysteine is mutated to glycine (C→G), while in the other
(IGFL1P2), the 2nd and 11th cysteines are bothmutated to serine
(C→S), suggesting further that these coding sequences are now
degenerating from the original presumed duplication sequence.
The single mouse IGFL gene maps to chromosome 7, region
XII (gi38086012). No other IGFL-type genes could be
identified in the mouse genome. Human chromosome 19 is a
small chromosome of ∼65 Mb [20,21], with the highest
reported density of genes, and the 19p13.3 band is syntenic with
chromosome 7, region XII, in the mouse. A search of the mouse
EST database (dbEST from GenBank) failed to reveal any new
members.
Mouse IGFL (IGFL_Mm) CDS spans four exons, similar to
the human IGFL genes. The exon pattern, however, is
substantially distinct. While the human IGFLs have the
conserved cysteine motifs in the third coding exon, in the
mouse they are contained within the second exon. The third
exon of IGFL_Mm does not contain any cysteine residues, and
the fourth encodes only the C-terminal amino acid.al features of the IGFL1 gene. The coding region is composed of four exons, of
protein. All other IGFL members have similar structural features. The cysteine
ons within the conserved cysteines. (B) Genomic clustering of IGFL genes and
val of chromosome 19. Arrows point in the direction of the coding frame. Red
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Comparison of the IGFL proteins with other known
secreted protein families demonstrated the closest similarity,
albeit at a low level, to the IGF family. This low similarity
is likely due to the fact that among the members of the IGF
family, the primary sequence is weakly conserved and the
members of this family are grouped together on the basis of
structural similarity [19].
Members of the IGF family are characterized by three
peptide sequences (A and B chains and the C peptide). The
C-peptide sequence acts as a connector between the A and
the B chains and the sizes of these C peptides vary greatly
among IGF family members (Fig. 3B). Within the A and B
chains, cysteine residues are conserved in a fixed register
and are involved in three disulfide bonds, two of which are
interchain (A and B peptides) and one of which is intrachain
(A peptide) (Fig. 3A). The cysteine motifs present are of the
form CGX10C for the B chain and CCX3CX8C for the A
chain. The IGFL family members conserve the pattern of
having a B chain followed by a C peptide and an A chain.
But while the IGFL family proteins maintain the same
cysteine motif for the B chain as in the IGFs, they present
an insertion in the A-chain motif between the initial cysteine
doublet and the third cysteine, which changes the motif to
CCX(19–23)CX8C (Fig. 3B). Analysis of the crystallographic
model of IGF1 (pdb Ref. 3GF1) shows that the correspond-
ing site of the A chain insertion would occur at the surface
of the protein in a position where it could be accommodated
without affecting the disulfide bond patterns for the A chain
(Fig. 3C). The overall low hydrophobicity values for all the
inserted sequences are consistent with this proposal and also
may indicate that this surface loop will not affect the
disulfide bonds.
The C peptide is cleaved and released from insulin
during proteolytic activation, though in most of the IGF
family members this cleavage does not occur [19]. Our
assessment of the molecular mass of the secreted form of
hIGFL1 is consistent with the retention of the C-peptide
sequence in the secreted form of the protein (Fig. 4).
The IGFL family members also present three additional
highly conserved cysteine residues within the C peptide that
define the novel cysteine motif CGXnCX4C, where n = 3 in all
the members except IGFL1, in which n = 2. There are no
cysteines in the C peptide of human IGFs, but there are in the
insulin-like peptides ILG, ILB1–5, and ILA1–3 in Caenor-Fig. 3. Alignment to IGFs and structural prediction of the IGFL family members. (A)
from the propeptide during maturation are separated by spaces. Disulfide bonds and t
The four members of the IGFL family and the mouse IGFL are aligned with members
(EPIL); INSL3, Leydig insulin-like peptide (LeyIL); INSL5, insulin-like peptide 5 pre
REL2, prorelaxin H2 precursor; IGF1B, insulin-like growth factor IB precursor; IGF1
IGFL sequences from Pan troglodytes, Canis familiaris, Bos taurus; BBXA, BBX
insulin-related peptide; MIP1, MIP2, MIP3, MIP5, MIP7, molluscan insulin-related
ILB1, ILB2, ILB3, ILB4, ILB5, ILB6, C. elegans β-type insulin-like peptide precu
conserved cysteines; *, other conserved positions. Lengths of the C peptides linking th
IGFL insertion loop would replace the IGF tripeptide FRS (indicated in yellow) [24habditis elegans and these have been proposed to participate in
other disulfide bonds [19].
IGFL genes produce secreted proteins
To verify the expression and secretion of the IGFL genes,
we isolated IGFL full-length cDNAs, engineered them as
epitope-tagged constructs (V5/His at the carboxyl terminus),
and transfected these into 293HEK cells. All IGFL genes
were expressed at the expected molecular weight in the
lysates of the transfected cells (Fig. 4). Although each gene
showed expression in the cell lysate, only IGFL1 demon-
strated secretion into the culture supernatant. The relative
mobilities of these proteins are difficult to estimate
accurately, as the empirical mass estimates would be in
the range of 13–16 kDa for an epitope-tagged, “full-length”
protein, while secreted, tagged IGFL would range from 9 to
12 kDa. It is possible that 293HEK cells lack the
appropriate pathway or proteins for the export of the other
family members.
Tissue expression profile of IGFL genes in Homo sapiens
To determine the tissue distribution of IGFL mRNAs, we
analyzed expression using real-time quantitative PCR (RT-
PCR) (Table 1). IGFL genes, in general, are rarely expressed.
We detected IGFL1 gene expression in ovary and the spinal
cord; IGFL2 expression in the cerebellum, heart, placenta,
spleen, stomach, testis, and thymus; and IGFL3 and IGFL4
expression in the cerebellum. IGFL-2 has the broadest
expression pattern among the IGFL genes and is highest in
the cerebellum. In addition, we failed to detect IGFL mRNA
expression in a broad range of tissues, including adrenal gland,
bone marrow, brain, breast, prostate, skin, small intestine,
thyroid, and uterus.
An alternate means of evaluating the expression of IGFL
genes is to assess the relative abundance of transcripts in EST
collections. Upon BLAST analysis of the GenBank human
EST database [23], IGFL1 expression was observed in
libraries derived from carcinoma cell lines, fetal skin, head
and neck tumor, normal breast, squamous cell carcinoma, and
a uterine tumor (data not shown). IGFL2 expression was
detected in colon tumors, fetal skin, testis, and umbilical cord,
while IGFL3 was found in epidermal keratinocytes, fetal heart,
and normal prostate. A single transcript of IGFL4 is currently
available in dbEST, likewise a single EST was identified forSchematic representation of vertebrate IGF and IGLF. Domains that are cleaved
he IGFL inserted loop are indicated. (B) Alignment of IGFLs with known IGFs.
of the insulin-related families. INSL4, human early placenta insulin-like peptide
cursor; INSL6, insulin-like peptide 6 precursor; REL1, prorelaxin H1 precursor;
A, insulin-like growth factor IA precursor; prCHIMP, prDOG, prCOW, predicted
B, BBXC, BBXD, Bombyx mori bombyxin A9, B1, C2, and D1; LIRP, locust
peptides; ILG1, Caenorhabditis elegans γ-type insulin-like peptide 1 precursor;
rsors; ILA1, ILA2, ILA3, C. elegans α-type insulin-like peptide precursors; C,
e B chain to the A chain are indicated. (C) Crystal structure of IGF. The proposed
].
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Fig. 4. Human IGFL protein expression in cell lysates and supernatants. Lysates
and conditioned medium of 293HEK cells transfected with IGFL cDNA
expression plasmids were tested by immunoblot analysis using an anti-V5
antibody.
Table 1
Relative expression of IGFL mRNAs in human tissues
cDNA source Sample number (n) IGFL1 IGFL2 IGFL3 IGFL4
Cerebellum 1 0.2 34.3 0.4 6.0
Colon 2 0.0 0.3 0.0 0.0
Heart 2 0.0 0.5 0.0 0.0
Kidney 2 0.1 0.1 0.0 0.0
Liver 4 0.0 0.0 0.0 0.0
Lung 2 0.0 0.1 0.0 0.0
Lymph node 1 0.0 0.2 0.0 0.1
Ovary 3 0.5 0.0 0.0 0.0
Pancreas 2 0.0 0.2 0.0 0.0
Placenta 3 0.0 3.6 0.0 0.1
Skeletal muscle 3 0.0 0.0 0.0 0.1
Spinal cord 1 1.1 0.2 0.0 0.0
Spleen 4 0.0 0.4 0.0 0.0
Stomach 1 0.0 9.7 0.1 0.3
Testis 3 0.1 5.9 0.1 0.0
Thymus 3 0.1 4.6 0.0 0.0
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IGLF proteins are present at very low levels.
Discussion
We have discovered a family of secreted proteins, IGFL, that
we propose shares structural homology with the IGF family.
IGFLs comprise small, secreted proteins with an average length
of less than 80 aa in the mature polypeptide and contain 11
cysteines including two CC motifs. In the human genome, four
transcribed family members and two pseudogenes cluster within
35 kb on chromosome 19, whereas the syntenic region of mouse
(chromosome 7) encodes a single family member. IGFL cDNAs
encode proteins that can be secreted into the extracellular
medium and the expression of these mRNAs in human tissues
appears to be relatively low.
Although IGFL genes represent interesting secreted proteins
in many respects, further analysis is required to define their
physiological functions. Other IGF family members are known
to be involved in major biologic processes: metabolic control,
growth, and reproduction [2]. Given the proposed structural
similarity with IGF proteins, IGFL proteins likely act as growth
modulators as well. The mRNA expression pattern of IGFL
genes supports this hypothesis in that RT-PCR analysis shows
that the IGFL genes are expressed in fetal epithelial tissues
where growth and differentiation tend to be high.
One of the most striking features of the IGFL family is the
difference between human and mouse members. In addition to
absolute number of IGFL genes in the two species, the mouse
gene lacks any direct orthology to the human family members.
IGFL_Mm is almost equally distant from all the human
members, with the highest homology between IGFL_Mm and
IGFL3 at only 37%. The clustered nature of the human family
within a very narrow region of the genome clearly points out a
recent duplication and diversification event; IGFL genes are
observed in most of the mammalian species for which there is
significant genomic sequence available. However, the highsequence divergence among the human genes and complete
lack of orthology to the mouse sequence would strongly suggest
a relatively relaxed selective pressure for this gene family.
From another perspective, human chromosome 19 is known
to have very high divergence from the mouse orthologue [22].
One reason for this divergence is the high variation in mutational
rates or repairing mechanisms in both the mouse and the human
genome. A second possibility is related to the isochore structures
(genomic segments that are homogeneous in base composition),
which are high in GC content. Chromosome 19 is known to
contain many gene families in clusters [21]. For example, a
single human ZNF gene is represented by a cluster of 12 closely
related ZNF genes in the homologous mouse region. Human-
specific cluster expansions have also been observed [21].
The biological activity of the IGFL molecules remains to be
defined. Our proposed structural comparison to the IGF family
suggests that these proteins could act as secreted growth
regulators. Generation of transgenic mouse systems or the
identification of in vitro biological activity will help to elucidate
their function. The discovery of novel, small, secreted proteins
can be difficult since low-level similarities between short length
proteins can be challenging to detect using traditional BLAST-
based approaches across diverse sequences. Our clustering
algorithms are useful in this regard in that they first identify
high-scoring clusters that point to candidate novel protein
families.
Materials and methods
Sequence assembly and gene discovery
DNA sequences were assembled from Nuvelo EST sequences and from
sequences available through the NCBI. Similar methods have been used
previously by others to estimate the number of independent genes within the
human genome [14]. Chromatograms from cDNA clones were obtained using
dideoxy sequencing and resolution on ABI 377/3700 sequencers or by
downloading chromatograms from the GenBank dbEST database [23].
PHRED was used for base-calling and to assign quality scores [15,16]. The
assembly was initiated using an EST sequence as a seed, followed by the
implementation of a recursive algorithm [9], which extended the seed into an
assemblage, using the assembly engines PHRAP and CAP4 [17,18]. Inclusion
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extending assemblage with BLAST score >300 and percentage identity greater
than 95%. The algorithm terminated when there were no additional sequences
that would extend the assemblage.
Specifically, the input to our assembly engine was a collection of public and
private EST sequences and predicted exons from the human genome. We used
1,693,594 proprietary EST sequences from Nuvelo, Inc., 3,468,643 EST
sequences from dbEST (H. sapiens, release 123), and 59,530 from gbpri (H.
sapiens) and 2,865,687 exons predicted from human genomic sequences. The
total of input sequences was 8,087,354. A total of 511,807 singletons and
4,791,461 contigs were generated from this assembly. The total contigs fall into
235,544 putative genes, among which over 50 bp overlaps were found. We
performed BLASTX searches against the Genpept database (version 123) and
excluded contigs that had a score of S = 100 or greater. Of the putative genes,
69,864 did not have a significant hit vs Genpept and represent our starting point
for clustering.
We performed TBLASTX searches of those 69,864 putative genes against
themselves. We clustered the genes into various families based on a BLAST
clustering score of S = 150 and above. We also extracted a predicted protein
sequence for each clustered sequence based on the TBLASTX alignment. We
ran a signal peptide prediction algorithm [16] on those putative protein
sequences and identified clusters that encode putative proteins that contain
signal peptide sequences and lack transmembrane segments. Multiple sequence
alignment files were generated for each cluster and then reviewed manually.
Full-length genes were edited using sequence information from the human
genome, EST/mRNA segments, and orthologous genes from other species when
available.
Cloning and expression of soluble IGFL genes
To clone IGFL genes, the full-length cDNAwas amplified from Marathon-
Ready cDNA libraries (Clontech, Palo Alto, CA, USA). PCR primers were
designed based on UTR sequences for primary amplification and the nested
PCR was conducted using gene-specific PCR primers. The final PCR product
was cloned into the pcDNA3.1/V5His TOPO vector (Invitrogen, Carlsbad, CA,
USA). For each IGFL gene, both wild-type and V5His-tagged clones were
generated and sequence verified.
To express recombinant IGFL proteins, mammalian expression plasmids
encoding IGFL cDNAs along with a control vector were transfected into
293HEK cells using the FuGENE-6 transfection reagent (Roche, Basel,
Switzerland). Forty-eight hours after transfection, both conditioned media and
cell lysates were harvested and analyzed by SDS–PAGE followed by Western
blot using anti-V5 antibody.
TaqMan analysis of gene expression
Materials
The following materials were used: (1) SYBR Green Master Mix (Applied
Biosystems, Foster City, CA, USA), (2) primers, (3) MicroAmp Optical 96-well
reaction plates, and (4) optical adhesive covers (Applied Biosystems).
Equipment
We used the GeneAmp 5700 sequence detection system. The PCR mix, for
each well, consisted of 12.5 μl 2× SYBR Green PCR Master Mix, 1 μl forward
primer (2.5 μM), 1 μl reverse primer (2.5 μM), 9.5 μl H2O. Reactions were run
as follows: 1× TaqGold activation, 95°C for 10 min, and 40 cycles of 15 s at
95°C and 30 s at 60°C.
Primers
PCR primers were selected using Primer3 (Whitehead Institute) and
typically flanked a segment of CDS of approx 250–350 bases. The primer pairs
were IGFL1forward, ATCTGCTGATCCCCTCCTCACTCC; IGFL1 reverse,
CATCCCAGATCTCAGGTAACACCAGC; IGFL2 forward, GAAATCATG-
AGGTTCAGTGTCTCAGGC; IGFL2 reverse, CCTATGTTTCTGAGAT-
GCCTTAGTGAAAGTTG; IGFL3 forward, TCCTAGAGCATCTTTGGA-
AGCATGAGG; IGFL3 reverse, GATGTCCAGCTGCTTCGTCTCTTCTC;
IGFL4 forward, ACTGACCCATTTCCACTGCTGCTC; and IGFL4 reverse,
TGATCTGTGACTCTGCTACCCCAGAAC.Data analysis
Elongation factor 1α (ELF-1α) was used as a normalization control. Two
independent samples were assayed and the resulting CT values were averaged. If
the CT value was greater than 38, the expression level was set to 0. For all other
CT values, the expression level of the IGFL gene was calculated using the
formula z = IGFL_ct − ELF-1α_ct; IGFL_expr = 2**(zmax − z), where ELF-
1α_ct and IGFL_ct are the average cycle counts of perspective genes, zmax is the
maximum of z among all tissues with a cycle count <36, and IGFL_expr is the
relative expression level of that IGFL gene among all tissues studied. A level of
1.0 for a IGFL gene in a tissue means that (1) CT < 36 and (2) it is the highest
cycle number among the tissues with CT < 36. This value is the base for
calculating the expression level of the same gene in other tissues. All expression
levels with CT above 38 were deemed not significant and were assigned an
expression level of 0.00.References
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